RNA-sequence and non-target metabolomics analysis were employed to further explore the function of GSTK1 and elucidate the molecular mechanism underlying GSTK1 on the tumor malignant phenotype (Figure S3A-D). This evidence concerns the gene GSTK1 and neoplasm.